Current conversations on dPCR and oncology

What role could dPCR play in developing cancer monitoring?

Over the past few months, we connected with oncohematology experts at the forefront of dPCR research. To hear their experience, results and thoughts on these questions, we compiled some highlights from our latest events.

Hear how standardization of molecular testing was achieved for patients with chronic myeloid leukemia (CML) and how this model could be used for other blood cancers.

Presented by: Prof. Susan Branford, SA Pathology

Listen to translational research conversations on the use of dPCR for liquid biopsies.

Presented by: Prof. Jo Vandesompele

Learn more about the potential of using dPCR to monitor response to treatments in patients affected by solid tumors.

Presented by: Dr. Marzia del Re